Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVXL

Anavex Life Sciences (AVXL)

Anavex Life Sciences Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVXL
DateTimeSourceHeadlineSymbolCompany
03/05/202419:45PR Newswire (US)Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/05/202421:30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
26/04/202419:45PR Newswire (US)May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
19/04/202419:45PR Newswire (US)Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)NASDAQ:AVXLAnavex Life Sciences Corporation
16/04/202419:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
12/04/202419:45PR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
11/04/202421:30GlobeNewswire Inc.Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
09/04/202419:45PR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
05/04/202420:45PR Newswire (US)Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/04/202420:45PR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
29/03/202420:45PR Newswire (US)Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
26/03/202420:45PR Newswire (US)Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
25/03/202422:30GlobeNewswire Inc.Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
22/03/202420:45PR Newswire (US)AVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:AVXLAnavex Life Sciences Corporation
18/03/202422:30GlobeNewswire Inc.Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
26/02/202423:30GlobeNewswire Inc.Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
23/02/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
23/02/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
23/02/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
23/02/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
23/02/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
08/02/202408:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
07/02/202423:30GlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
01/02/202423:30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
26/01/202409:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVXLAnavex Life Sciences Corporation
24/01/202423:30GlobeNewswire Inc.Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in HumansNASDAQ:AVXLAnavex Life Sciences Corporation
16/01/202423:30GlobeNewswire Inc.Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
13/01/202412:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
08/01/202423:30GlobeNewswire Inc.Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental DisordersNASDAQ:AVXLAnavex Life Sciences Corporation
03/01/202423:30GlobeNewswire Inc.Anavex to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:AVXL